InspireMD (NYSEAMERICAN:NSPR) will be posting its quarterly earnings results on Wednesday, March 28th.
InspireMD (NYSEAMERICAN:NSPR) last announced its earnings results on Wednesday, February 14th. The medical equipment provider reported ($7.38) EPS for the quarter. InspireMD had a negative net margin of 179.74% and a negative return on equity of 720.33%. The business had revenue of $0.83 million for the quarter.
Shares of InspireMD (NYSEAMERICAN:NSPR) opened at $2.17 on Monday. InspireMD has a twelve month low of $0.70 and a twelve month high of $36.75. The company has a market cap of $7.11, a P/E ratio of -0.12 and a beta of 2.61.
InspireMD Company Profile
InspireMD, Inc is a medical device company. The Company is focusing on the development and commercialization of its MicroNet stent platform technology for the treatment of vascular and coronary disease. Its MicroNet, a micron mesh sleeve, is wrapped over a stent to provide embolic protection in stenting procedures.
Receive News & Ratings for InspireMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InspireMD and related companies with MarketBeat.com's FREE daily email newsletter.